Nonwoven manufacturer Nan Liu Enterprise Co Ltd (南六) yesterday said it expected its capacity to produce spunlace nonwovens would increase 60 percent to 3,800 tonnes per month by the end of this year, making it the top provider across the Taiwan Strait.
Spunlace nonwoven is a major raw material used to make surgical gowns, drapes and wipes used in many industries.
Sales of spunlace nonwoven products accounted for 56 percent of Nan Liu’s total revenue, with its major markets in Asia.
Because of the technological know-how and high capital investment required for firms to enter the market, only Dupont and Nan Liu have the ability to produce medical-grade spunlace nonwovens.
Additionally, only Dupont, Polymer Group Inc, Nan Liu and some Chinese firms are able to produce spunlace nonwovens for industrial use, Nan Liu’s commercial director said at a pre-initial public offering (IPO) conference for investors yesterday.
The company, which is scheduled to move the trading of its shares to the Taiwan Stock Exchange early next month from the Emerging Stock Market, has tentatively set an IPO price of NT$50 a share.
It plans to raise NT$405 million (US$13.5 million) from the IPO by issuing 8.1 million new shares.
Nan Liu reported revenue of NT$971.89 million from January through last month, up 16.59 percent from NT$833.62 million a year ago, which the company attributed to new product launches.
It did not provide comparative numbers for the fourth quarter last year.
Last year, Nan Liu reported net profit of NT$197 million, up 41.26 percent from NT$139.46 million in 2011.
Nan Liu’s shares closed flat at NT$67.5 on the Emerging Stock Market yesterday.